Currently, there are approximately 120 active obesity drug programs under development in China, spanning a range of mechanisms from GLP-1 and amylin analogues to entirely novel peptide classes
Its important to allow sufficient time for the medication to clear from the body before assuming a diagnosis of gastroparesis
This difference is attributed to the incretin hormones, GLP-1 and GIP, which are released in response to orally received, but not systemically delivered, glucose
Serious Risks to Watch For Pancreatitis (severe abdominal pain) Thyroid tumors Hypoglycemia Gallstones or acute cholecystitis If you think youre experiencing any of these issues, speak with a healthcare provider immediately
These steps are summarised in Figure 2
Omzo publishes a HIPAA Privacy Policy at omzo.com/hipaa-policy